Stage IB Pancreatic Cancer Completed Phase 2 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0034490 (Stage IB Pancreatic Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01959672Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic CancerTreatment